European equities traded in the US as American depositary receipts were tracking slightly lower late Monday morning, declining 0.30% to 1,727.53 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and pharmaceutical company Novo Nordisk (NVO), which rose 3.8% and 1.8% respectively. They were followed by oil and gas company Eni (E) and petroleum refiner Equinor (EQNR), which were up 1.5% and 1.4% respectively.

The decliners from continental Europe were led by biotech firm Evaxion (EVAX) and accommodations reservations site trivago (TRVG), which fell 4.2% and 3.7% respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and internet advertising firm Criteo (CRTO), which were down 2.2% 1.7% respectively.

From the UK and Ireland, the gainers were led by biotech frim Autolus Therapeutics (AUTL) and pharmaceutical company Silence Therapeutics (SLN), which increased 5.6% and 3.5% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Bicycle Therapeutics (BCYC), which advanced 2.7% and 2.1% respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biotech firm Trinity Biotech (TRIB), which dropped 5.9% and 5.1% respectively. They were followed by biopharmaceutical companies NuCana (NCNA) and Mereo BioPharma Group (MREO), which lost 4.4% and 2.6% respectively.

Price: 23.23, Change: +1.36, Percent Change: +6.20